arrow
Back
I

Irene L. Noronha

universidade de sao paulo

37H-index
204Paper Count
4.9KCitation Count
Published Papers 48
Publication Date
Global landscape of kidney health across Indigenous populations
err2025-10-16
err0
PREAI
errSomkanya Tungsanga; Ikechi G. Okpechi; Maria Eugenia V. Bianchi; Swasti Chaturvedi; David Collister; Harley Crowshoe; Giselle M. Rodriguez de Sosa; Habibu A. Galadanci; Erin Hedin; Kwaifa S. Ibrahim; Arsh K. Jain; Irene L. Noronha; Robin L. Erickson; Jaquelyne T. Hughes; Paul Komenda; Win Kulvichit; Roberto Pecoits-Filho; Kalani L. Raphael; Vallabh O. Shah; Malama Tafuna’i; Caroline Tait; Catherine Turner; Curtis Walker; Robert Walker; Cathy Woods; Adeera Levin; Aminu K. Bello
errShare
errSave
Targeted treatment with pegcetacoplan for post-transplant recurrent C3G or primary (idiopathic) IC-MPGN in the VALIANT phase 3 trial
err2025-10-01
err0
errOAAI
errOosterveld, Michiel Js; Kaufeld, Jessica; Zecher, Daniel; Claes, Kathleen; Zuber, Julien; Noronha, Irene L.; Bomback, Andrew S.; Wang, Zhongshen; Szamosi, Johan; Li, Li; Lopez-Lazaro, Luis; Viklicky, Ondrej
errShare
errSave
Removal of middle molecules with hemoadsorption plus hemodiafiltration in kidney failure patients
err2025-10-01
err0
errOAAI
errReis, Thiago; Guimaraes, Maria Gabriela; Pecoits-Filho, Roberto; Andrade, Jessica; Braga, Sibele; MacIel, Gisele Guimaraes; Goes, Miguel; Kitawara, Koody; Ramirez-Guerrero, Gonzalo; Neves, Francisco; Ronco, Claudio; Noronha, Irene L.
errShare
errSave
Pirfenidone, a drug intended to treat idiopathic pulmonary fibrosis, prevented CKD progression in an experimental model of hypertensive nephrosclerosis
err2025-10-01
err0
errOAAI
errPereira, Camile; Fanelli, Camilla; Francini, Ana Laura Rubio; Vieira, Giovanna; Margolin, Solomon; Noronha, Irene L.
errShare
errSave
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
err2025-09-18
err0
errOAAI
errJürgen Floege; Jonathan Barratt; H. Terence Cook; Irene L. Noronha; Heather N. Reich; Yusuke Suzuki; Sydney C.W. Tang; Hernán Trimarchi; Ethan M. Balk; Craig E. Gordon; Gaelen P. Adam; Marcello A. Tonelli; Amy Earley; Brad H. Rovin
errShare
errSave
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
err2025-09-18
err0
errOAAI
errBrad H. Rovin; Jonathan Barratt; H. Terence Cook; Irene L. Noronha; Heather N. Reich; Yusuke Suzuki; Sydney C.W. Tang; Hernán Trimarch; Jürgen Floege
errShare
errSave
Dengue infection as a trigger for Collapsing Glomerulopathy in patients with APOL1 high-risk genotype
err2025-08-11
err0
errOAAI
errPrecil D.M.M. Neves; Luana C.S. Silva; Maria E.V.C. Pereira; Felipe A.M. Oliveira; Stanley A. Araújo; David C. Wanderley; Felipe L. Ledesma; Alekssia L. Guedes; Bárbara H. Loos; Andressa T. Ribeiro; Andréia Watanabe; Elieser H. Watanabe; Gilson M. Murata; Gyl E.B. Silva; José M. Vieira-Júnior; Natália C.V. Melo; Denise M.A.C. Malheiros; Irene L. Noronha; Luiz F. Onuchic
errShare
errSave
Metabolic disorder–associated kidney disease and diabetic kidney disease in developing countries
err2025-06-27
err0
PREAI
errSunita Bavanandan; Irene L. Noronha; Irma Tchokhonelidze; Adrian Liew
errShare
errSave
Adipose Tissue Stem Cells (ASCs) and ASC-Derived Extracellular Vesicles Prevent the Development of Experimental Peritoneal Fibrosis
errCELLS
IF5.2
err2025-03-14
err0
errOAAI
errGouveia, Priscila Q.; Fanelli, Camilla; Ornellas, Felipe M.; Garnica, Margoth R.; Francini, Ana L. R.; Murata, Gilson M.; Matheus, Luiz H. G.; Morales, Marcelo M.; Noronha, Irene L.
errShare
errSave
Extracellular Vesicles (EVs) Derived from Mesenchymal Stem Cells (MSCs) as Adjuvants in the Treatment of Chronic Kidney Disease (CKD)
errCELLS
IF5.2
err2025-03-14
err0
errOAAI
errNoda, Paloma; Francini, Ana L. R.; Teles, Flavio; Junior, Samuel J.; Fonseca, Fernando L. A.; Borges, Fernanda T.; Sobrinho, Adao C.; Taniwaki, Noemi; Noronha, Irene L.; Fanelli, Camilla
errShare
errSave
Endothelin receptor antagonists in chronic kidney disease
err2024-12-06
err0
PREAI
errSmeijer, J. David; Kohan, Donald E.; Dhaun, Neeraj; Noronha, Irene L.; Liew, Adrian; Heerspink, Hiddo J. L.
errShare
errSave
Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions
err2024-09-01
err3
PREAI
errGirardi, Adriana C. C.; Polidoro, Juliano Z.; Castro, Paulo C.; Pio-Abreu, Andrea; Noronha, Irene L.; Drager, Luciano F.
errShare
errSave
Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study
err2024-04-01
err0
errOAAI
errTrachtman, Howard; Radhakrishnan, Jai; Rheault, Michelle N.; Alpers, Charles E.; Barratt, Jonathan; Heerspink, Hiddo J. L.; Noronha, Irene L.; Perkovic, Vlado; Rovin, Brad; Trimarchi, Hernan; Wong, Muh Geot; Mercer, Alex; Inrig, Jula; Rote, William; Murphy, Ed; Bedard, Patricia W.; Roth, Sandra; Bieler, Stewart; Komers, Radko
errShare
errSave
Idiopathic collapsing glomerulopathy is associated with APOL1 high-risk genotypes or Mendelian variants in most affected individuals in a highly admixed population
err2024-03-01
err2
errOAAI
errNeves, Precil; Watanabe, Andreia; Watanabe, Elieser; Narcizo, Amanda; Nunes, Kelly; Lerario, Antonio; Ferreira, Frederico; Cavalcante, Livia; Wongboonsin, Janewit; Malheiros, Denise; Jorge, Lecticia; Sampson, Matthew; Noronha, Irene; Onuchic, Luiz
errShare
errSave
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
err2023-12-28
err34
PREAI
errRheault, Michelle N.; Alpers, Charles E.; Barratt, Jonathan; Bieler, Stewart; Canetta, Pietro; Chae, Dong-Wan; Coppock, Gaia; Diva, Ulysses; Gesualdo, Loreto; Heerspink, Hiddo J. L.; Inrig, Jula K.; Kirsztajn, Gianna M.; Kohan, Donald; Komers, Radko; Kooienga, Laura A.; Lieberman, Kenneth; Mercer, Alex; Noronha, Irene L.; Perkovic, Vlado; Radhakrishnan, Jai; Rote, William; Rovin, Brad; Tesar, Vladimir; Trimarchi, Hernan; Tumlin, James; Wong, Muh Geot; Trachtman, Howard
errShare
errSave
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
errLANCET
IF88.5
err2023-12-01
err75
PREAI
errRovin, Brad H.; Barratt, Jonathan; Heerspink, Hiddo J. L.; Alpers, Charles E.; Bieler, Stewart; Chae, Dong-Wan; Diva, Ulysses A.; Floege, Juergen; Gesualdo, Loreto; Inrig, Jula K.; Kohan, Donald E.; Komers, Radko; Kooienga, Laura Ann; Lafayette, Richard; Maes, Bart; Malecki, Robert; Mercer, Alex; Noronha, Irene L.; Oh, Se Won; Peh, Chen Au; Praga, Manuel; Preciado, Priscila; Radhakrishnan, Jai; Rheault, Michelle N.; Rote, William E.; Tang, Sydney C. W.; Tesar, Vladimir; Trachtman, Howard; Trimarchi, Hernan; Tumlin, James A.; Wong, Muh Geot; Perkovic, Vlado
errShare
errSave
Virtual crossmatch: Could all HLA-DQB1*03:01P antigens be analyzed in the same way?
err2023-09-01
err0
PREAI
errFantini, R.; de Marco, R.; Martins Lima, A.; Bottino, L. Z.; Noronha, I.; Machado, A.; Gerbase de Lima, M.
errShare
errSave
Description of a novel HLA-DQαβ epitope formed by two self-residues and validated by adsorption/elution
err2023-09-01
err1
PREAI
errMartins Lima, A.; de Marco, R.; Noronha, I.; Fantini, R.; Gerbase de Lima, M.
errShare
errSave